Can we afford weight-loss drugs for all?

Obesity and associated health problems cause a significant burden
on health systems, but should weight-loss drugs be offered under
our PBS just for weight loss?  


In Britain, there is to be a trial of the weight loss drug
Mounjaro, that will also seek to measure the economic impact of
those benefits.  Britain's Health Minister argues that
weight loss drugs will be '"life-changing, help them get back to
work and ease the demands on our NHS". 


Guests:


Dr Norman Swan, co-presenter of ABC Radio National's Health
Report, and the podcast 'What's That Rash?'


Jonathan Karnon, Professor of Health Economics at Flinders
University


Nial Wheate, Pharmaceutical Chemist and Professor of Academic
Excellence at Macquarie University 


And the Albanese Government this week announced a crack down on
unfair and excessive card surcharges, promising to get a better
deal for Australians and small business.  The declining use
of cash and the rise of electronic payments means more
Australians are getting hit by often hidden surcharges.  


Guest:


Brad Kelly, Co-founder of the Independent Payment Forum